| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.29 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |